American Portfolios Advisors’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$23.5K Buy
103
+81
+368% +$20.6K ﹤0.01% 2107
2022
Q2
$5.11K Buy
+22
New +$4.83K ﹤0.01% 2819

Other funds holding ACET

American Portfolios Advisors's ACET Position: Q3 2022 in Review

American Portfolios Advisors increased its Adicet Bio (ACET) stake by 368% in Q3 2022, buying an estimated $20.6K and bringing the position to 103 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

American Portfolios Advisors first reported a position in ACET in Q2 2022 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold ACET as of Q3 2022.

  • American Portfolios Advisors held 103 shares of Adicet Bio worth $23.5K as of Q3 2022.
  • American Portfolios Advisors bought 81 Adicet Bio shares in Q3 2022, an estimated $20.6K.
  • Adicet Bio made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2107 holding.
  • American Portfolios Advisors first reported a position in Adicet Bio in Q2 2022 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.